Remarkably, the EZH2–E2F1 complex was found to mechanistically modulate chromatin accessibility, thereby promoting cancer cell proliferation while inhibiting G2/M phase arrest and apoptosis in TNBC (Fig. 3). Here, EZH2 is linked to cancer.